Shares of Clariant AG (OTCMKTS:CLZNY – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, two have issued a buy recommendation and two have issued a strong buy recommendation on the company.
CLZNY has been the topic of a number of research reports. Barclays upgraded Clariant to an “overweight” rating in a research report on Monday, August 3rd. Jefferies Financial Group upgraded Clariant from a “moderate sell” rating to a “hold” rating in a research report on Thursday, August 6th. The Goldman Sachs Group raised Clariant to a “strong-buy” rating in a report on Thursday, August 20th. Deutsche Bank Aktiengesellschaft upgraded Clariant from a “hold” rating to a “buy” rating in a research report on Monday, August 3rd. Finally, Zacks Research raised Clariant from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 21st.
Get Our Latest Analysis on CLZNY
Clariant Stock Performance
Clariant Company Profile
Clariant AG is a Switzerland-based specialty chemicals company that traces its roots back to a spin-off from Sandoz in 1995. Headquartered in Muttenz near Basel, the firm develops, manufactures and markets a broad portfolio of chemical solutions for industries worldwide. While its primary listing is on the SIX Swiss Exchange, Clariant’s shares also trade OTC under the symbol CLZNY, reflecting its global investor reach.
The company operates through three core segments: Care Chemicals, Catalysis and Natural Resources.
See Also
- Five stocks we like better than Clariant
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.
